Primus In News
Indian CDMOs get a growth pill
28-01-2026
Nilaya Varma, Group CEO and Co-Founder, Primus Partners, shared his view that the free trade agreement would open access to Europe’s pharmaceutical and medical devices market, valued at around $572 billion, while strengthening India’s position as a global manufacturing hub.
Explore Related Insights
- India represents 17-20 pc of gamers in $200 billion global industry: Experts
- Novartis Vymada patent revoked, generics set to slash prices by 70%
- $174 billion on the brink: India’s textile industry reels under West Asia war shock, braces for ‘huge crisis’ in April
- Hits & Misses of The Aviation Sector in 10 Years
